HomeOpen Access NewsDrug Development

Drug Development

Subscribe to Updates

University of Surrey joins global project to create immune digital twins

Pharma
Researchers at the University of Surrey are creating immune digital twins, virtual models of individual immune systems, to advance personalised medicine and deliver tailored treatments.

Antimicrobial resistance now kills more people than HIV or malaria

Pharma
According to a new study in The Lancet, antimicrobial resistance is now a leading cause of death worldwide, higher than HIV/AIDS or malaria.

WHO supports two new drugs for COVID-19 treatment

Health & Social Care
The two drugs, tested across seven trials on 4,000 COVID patients, can protect the immune system from overloading and lessen chances of ventilation.

Potential kidney damage from long-term use of blood pressure drugs

Health & Social Care
Research from the University of Virginia School of Medicine brings attention to the dangers of long-term use of blood pressure medication

Universal COVID vaccines can learn from the common cold

Health & Social Care
Research shows that T cells, created by the common cold, can give some protection against COVID - which means that universal vaccines can mimic this technology.

COVID vaccine can cause temporary change to menstruation cycle

Health & Social Care
Scientists analysed 23,754 menstrual cycles to find that menstruation can be temporarily, harmlessly changed - by taking two mRNA vaccines during the same cycle.

FDA approves new long-lasting drug for HIV prevention

Diseases & Conditions
December saw monumental steps being taken in HIV prevention with the FDA approving their first approval of long-acting HIV prevention medication.

Scientists to identify depression and antidepressant efficiency via blood tests

Research & Innovation
Researchers at the University of Chicago are believed to be one step closer in the development of blood tests to identify depression.

Convidecia vaccine 57.5% effective against symptomatic COVID

Research & Innovation
Phase Three trial shows Convidecia vaccine 57.5% effective against symptomatic COVID, while 91.7% effective against severe COVID.

Getting personal in brain tumour therapy: Matching therapies to patients

Health & Social Care
Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field

Metformin: A possible new treatment for endometriosis

Health & Social Care
Dr Deborah Lee, Dr Fox Online Pharmacy, discusses a possible new treatment for endometriosis - the condition that impacts atleast 1.5 million women in the UK.

New Pfizer Covid-19 pill seeking emergency use authorization from FDA

Pharma
Pfizer have announced that it is seeking emergency use authorization for its new Covid-19 oral antiviral candidate PAXLOVID™

How to compete with COVID-19 with a computer?

Research & Innovation
Y-h. Taguchi, Professor at Chuo University in Japan, reveals how to compete with COVID-19 by using a computer.

Pfizer COVID-19 pill 89% effective against death

Research & Innovation
Pfizer has announced that its antiviral pill, PAXLOVID, is 89% effective in reducing COVID-19 hospitalisation and death.

New “clickable” COVID vaccine patch in early stages of testing

Research & Innovation
The University of Texas is creating a COVID vaccine patch, which can protect against the virus - without the use of a needle.

UK creates deal for 480,000 doses of Merck COVID pill

Health & Social Care
The Merck COVID pill, molnupiravir, cuts risk of death by 50% - now, the UK have secured 480,000 doses for late 2021.

New cancer treatment creates best “overall survival ever”

Cancer Research
A new cancer treatment, an immunotherapy combination as opposed to gruelling chemotherapy, is saving the lives of head and neck cancer patients.
1...8910Page 9 of 10

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd